Unternehmen Centrexion Therapeutics Corporation
Aktien
A2N8XT
US15643W1009
CNTX
Biotechnologie
Kurzporträt
Mitarbeiterzahl: 24
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Founder | 76 | 01.02.13 | |
Jeffrey Kindler
FOU | Founder | 68 | 01.02.13 |
Chief Tech/Sci/R&D Officer | - | 01.04.15 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Joseph Swedish
BRD | Director/Board Member | 72 | 26.06.18 |
Sol Barer
FOU | Founder | 76 | 01.02.13 |
Jeffrey Kindler
FOU | Founder | 68 | 01.02.13 |
Peter Wirth
BRD | Director/Board Member | 73 | - |
Director/Board Member | 83 | 01.02.13 | |
Daniel Mendelson
BRD | Director/Board Member | 60 | 15.08.18 |
Hong Bo Lu
BRD | Director/Board Member | 53 | 01.01.19 |
Founder | 76 | 01.02.13 | |
Sara Nayeem
BRD | Director/Board Member | 75 | 01.01.18 |
Shawn Tomasello
BRD | Director/Board Member | 65 | 26.06.17 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 1 669 866 | 0 | 0 | - |
Unternehmenskontakt
Centrexion Therapeutics Corp.
200 State Street 6th floor
02109, Boston
+617-837-6911
http://www.centrexion.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+1.12% | 43.84 Mrd. | |
+6.77% | 41.68 Mrd. | |
+45.26% | 41.25 Mrd. | |
-11.96% | 27.04 Mrd. | |
+6.01% | 25.53 Mrd. | |
-24.92% | 18.18 Mrd. | |
-3.63% | 12.29 Mrd. | |
+27.16% | 12.29 Mrd. | |
+7.30% | 11.15 Mrd. |